Clinical Trials on Acquired Immunodeficiency Syndrome Virus

Total 6768 results

Catholic University of the Sacred Heart

Completed

Atazanavir/r + Lamivudine Dual Therapy (ATLAS)

Human Immunodeficiency Virus

Italy
University of Melbourne
Melbourne Health; National Institute of Allergy and Infectious Diseases (NIAID) and other collaborators

Completed

Effect of High Dose Vitamin D Supplementation on HIV Latency (VIVA)

Human Immunodeficiency Virus

Australia
University of North Carolina, Chapel Hill
Merck Sharp & Dohme LLC

Completed

Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Tract of HIV-Positive Adults

Human Immunodeficiency Virus

United States
Hunter College of City University of New York
National Institute on Alcohol Abuse and Alcoholism (NIAAA); Gilead Sciences

Completed

Intervention to Enhance PrEP Uptake and Adherence in a Community-Based Setting (SPARK)

Human Immunodeficiency Virus (HIV)

United States
ViiV Healthcare
Pfizer

No longer available

A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Commercial Availability Of Maraviroc (Celsentri) In India

Human Immunodeficiency Virus (HIV)
Incyte Corporation

Terminated

Randomized, Double-Blind Study Comparing Dexelvucitabine (DFC) to Lamivudine (3TC) in Subjects With Resistance to NRTIs, PIs, and NNRTIs (DECLARE)

HIV Infections | Human Immunodeficiency Virus

United States, Puerto Rico
Rockefeller University

Completed

3BNC117 and 10-1074 in HIV Uninfected Adults

Human Immunodeficiency Virus

United States
Cepheid

Completed

Clinical Evaluation of the Xpert® HIV-1 VL

Human Immunodeficiency Virus
International Partnership for Microbicides, Inc.

Completed

A Trial to Assess the Functionality of Female Condom With a Silicone Elastomer Vaginal Ring

Human Immunodeficiency Virus

United States
St. Jude Children's Research Hospital
National Institutes of Health (NIH)

Completed

Evaluate Tolerability of a Recombinant DNA HIV-1 Vaccine in Healthy Adults

HIV Infections | Human Immunodeficiency Virus

United States
RAND

Completed

Improving Drug Adherence Among Adolescents in Uganda Using SMS Reminders (RATA)

Human Immunodeficiency Virus

Uganda, United States
Merck Sharp & Dohme LLC

Completed

A Study of Raltegravir in a Diverse Cohort of HIV-Infected Patients (0518-055)

Human Immunodeficiency Virus
Ningbo No. 1 Hospital
The Affiliated Hospital of Medical College, Ningbo University

Completed

Randomized Controlled Trial of Shang Ring Male Children Circumcision: Comparison Between Flip and No Flip Technique

Human Immunodeficiency Virus

China
Hektoen Institute for Medical Research
National Institute of Allergy and Infectious Diseases (NIAID)

Unknown

Feasibility of an Ingestible Sensor System to Measure PrEP Adherence in YMSM

Human Immunodeficiency Virus
Centre for the AIDS Programme of Research in South...
ViiV Healthcare

Withdrawn

Safety and Acceptability of Cabotegravir in HIV Uninfected Women in KwaZulu-Natal, South Africa (CAPRISA014)

Human Immunodeficiency Virus

South Africa
Henry Ford Health System
Merck Sharp & Dohme LLC

Completed

Post-Exposure Prophylaxis in Health Care Workers (PEP)

Human Immunodeficiency Virus

United States
RFS Pharma, LLC

Withdrawn

A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects

Human Immunodeficiency Virus Infection
Kainos Medicine Inc.

Completed

Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023

Human Immunodeficiency Virus

Korea, Republic of
Pfizer

Completed

Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing Regimen

Human Immunodeficiency Virus

United States, Spain, South Africa, Italy, France, Germany
Pfizer

Completed

A Study To Investigate The Clearance Of PF-04776548 From The Body Following A Very Low (Micro) Dose Of The Compound Using A Low Level Of Radiotracer To Help Quantify Expected Low Concentrations Of PF-04776548 In The Body

Human Immunodeficiency Virus (HIV)

United Kingdom
Lederle Laboratories

Completed

An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects

HIV Infections

United States
University of Colorado, Denver
National Cancer Institute (NCI)

Recruiting

V+PSF-M for Tobacco Cessation in HIV Care in India

Smoking Cessation | Human Immunodeficiency Virus | Smoking, Tobacco

United States, India
University of California, San Francisco
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2)

Malaria | Human Immunodeficiency Virus

Uganda
University of California, San Francisco
Massachusetts General Hospital; Aga Khan University; University of Utah; Texas... and other collaborators

Completed

The Efficacy of the HIV/AIDS Symptom Management Manual

Acquired Immunodeficiency Syndrome | HIV

United States, Kenya, Puerto Rico, South Africa
Shaman Pharmaceuticals

Completed

A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients

HIV Infections | Diarrhea

United States, Puerto Rico
University of British Columbia
Simon Fraser University

Recruiting

The Positively Dance Pilot Program for Women Living With HIV (Dance)

Human Immunodeficiency Virus

Canada
Johns Hopkins University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Rapid HIV Treatment Initiation, Access and Engagement in Care

Human Immunodeficiency Virus

United States
Rockefeller University
Aarhus University Hospital; University Hospital of Cologne

Completed

Romidepsin Plus 3BNC117 Phase 2a Study (ROADMAP)

Human Immunodeficiency Virus (HIV)

Germany, Denmark, United States
Kenneth H. Mayer, MD
Gilead Sciences

Completed

HIV Non-Occupational Post-Exposure Prophylaxis (QUAD)

Human Immunodeficiency Virus

United States
Rockefeller University
National Institute of Allergy and Infectious Diseases (NIAID); Montefiore Medical... and other collaborators

Completed

3BNC117 and 10-1074 in ART-treated Individuals

Human Immunodeficiency Virus

United States
Columbia University
National Institute of Mental Health (NIMH)

Completed

A Combination HIV Prevention Strategy for Young Women at Risk for HIV (IPrEP)

Human Immunodeficiency Virus

Kenya
CytoDyn, Inc.

Active, not recruiting

An Extension Protocol for Subjects Who Successfully Completed PRO140_CD02 Study

Hiv | Human Immunodeficiency Virus
CytoDyn, Inc.

Active, not recruiting

An Extension of Protocol PRO 140_CD01 TS Study

HIV | Human Immunodeficiency Virus

United States
University of Colorado, Denver
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Mother and Infant Visit Adherence and Treatment Engagement Study (MOTIVATE!)

Human Immunodeficiency Virus

Kenya
Sangamo Therapeutics

Completed

Repeat Doses of SB-728mR-T After Cyclophosphamide Conditioning in HIV-Infected Subjects on HAART

Human Immunodeficiency Virus (HIV)

United States
Makerere University

Completed

Improving Outcomes in HIV Patients Using Mobile Phone Based Interactive Software Support (Callforlife)

Human Immunodeficiency Virus

Uganda
Elizabeth Glaser Pediatric AIDS Foundation
Johns Hopkins University; United States Agency for International Development... and other collaborators

Completed

A Multidisciplinary "Integrated Management Team to Improve Maternal-Child Outcomes (IMPROVE)" Intervention to Improve Maternal and Child Outcomes in Lesotho (IMPROVE)

Human Immunodeficiency Virus
Youth Development Labs, Inc dba YLabs

Completed

Optimizing Retention in Care and Adherence to Anti-retroviral Therapy Amongst Adolescents Living With HIV in Rwanda

Human Immunodeficiency Virus
FHI 360
Center for Population and Reproductive Health, University of Ibadan

Terminated

Using Social Media to Improve ART Retention and Treatment Outcomes Among YLHIV in Nigeria (Y-SMART)

Human Immunodeficiency Virus

Nigeria
ASST Fatebenefratelli Sacco
Elisa Colella, M.D.; Valentina Di Cristo, M.D.; Massimo Galli, M.D.

Completed

DRV/r + RPV QD: Efficacy and Toxicity Reduction

Human Immunodeficiency Virus

Italy
University College Dublin

Unknown

Mater-Bronx Rapid HIV Testing Project. (M-BRiHT)

Human Immunodeficiency Virus

Ireland
Erasmus Medical Center

Completed

The Dolutegravir Antiretroviral Mono-Therapy for HIV Trial (DOMONO)

Human Immunodeficiency Virus

Netherlands
University of Pennsylvania
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected Patients

Human Immunodeficiency Virus (HIV)

United States
James Egan
National Institute of Mental Health (NIMH); Fenway Community Health

Completed

Feasibility of Short-Term PrEP Uptake for MSM With Episodic High-Risk for HIV

Human Immunodeficiency Virus

United States
Medical College of Wisconsin
National Institute of Mental Health (NIMH)

Completed

Regular HIV Testing Among At-Risk Latino Men

Human Immunodeficiency Virus (HIV)
Janssen Vaccines & Prevention B.V.

Completed

Safety, Tolerability and Immunogenicity Study of Different Vaccine Schedules With Ad26.Mos.HIV and Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Adults

Healthy

United States
University of North Carolina, Chapel Hill
Centers for Disease Control and Prevention; Centre for Infectious Disease Research...

Completed

ART Readiness in HIV-infected Pregnant Women

Human Immunodeficiency Virus

Zambia
PATH
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaborators

Completed

Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis (TMC278LA)

Human Immunodeficiency Virus (HIV)

United States, South Africa, Zimbabwe
Rockefeller University
University Hospital of Cologne

Completed

3BNC117 and 10-1074 in HIV-infected Individuals

Human Immunodeficiency Virus (HIV)

United States, Germany
International Partnership for Microbicides, Inc.

Completed

Functionality of Male Condoms With a Silicone Elastomer Vaginal RIng

Human Immunodeficiency Virus

United States

Clinical Trials on Acquired Immunodeficiency Syndrome Virus

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations